SREBF2 and urinary bladder cancer: The Gene Expression Profiling Interactive Analysis (GEPIA) database (source from TCGA) showed that among PRKAA1 (AMPK), SREBP2 and HMGCR, only low expression of SREBP2 in bladder cancer patients showed higher overall survival rates (Figure S2A).